Free tool
Stocks listed on London
We cover 74 companies listed on London. The median market value in the group is $46.75M. Across the group, the median move over the past trading day is 0.00%. 39% of the 74 with a 200-day average trade above it. Price change over the past year runs from −60.9% to +74.5% across the middle 80 percent of the group, with a median of −7.6%.
Other lists in this group
Table
74 of 3,049 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% |
| GSK.L | GSK plc | 1,905.50 GBP | −5.06% | +4.06% | +30.59% |
| HLN.L | Haleon plc | 369.60 GBP | −2.66% | −0.12% | +2.68% |
| SN.L | Smith & Nephew plc | 1,068.00 GBP | −12.06% | −12.27% | −22.42% |
| UPR.L | Uniphar plc | 370.00 GBP | −1.33% | +23.75% | +6.94% |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% |
| AMS.L | Advanced Medical Solutions Group plc | 281.50 GBP | +0.36% | +29.14% | +38.01% |
| CRW.L | Craneware plc | 1,272.00 GBP | +2.75% | −33.40% | −40.83% |
| AGY.L | Allergy Therapeutics plc | 5.60 GBP | −5.08% | −52.94% | −30.00% |
| AVCT.L | Avacta Group Plc | 69.50 GBP | +0.72% | +20.87% | +26.36% |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% |
| OPT.L | Optima Health plc | 240.50 GBP | +1.48% | +20.85% | +9.32% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| IDHC.L | Integrated Diagnostics Holdings plc | $0.55 | −9.00% | −21.91% | +16.89% |
| TSTL.L | Tristel plc | 425.00 GBP | +1.19% | −2.84% | +19.76% |
| AOTI.L | AOTI, Inc. | 142.50 GBP | +35.71% | +418.18% | +159.09% |
| DXRX.L | Diaceutics PLC | 143.50 GBP | +8.71% | +11.67% | +4.36% |
| EKF.L | EKF Diagnostics Holdings plc | 24.70 GBP | −5.00% | −6.97% | −15.56% |
| SCLP.L | Scancell Holdings plc | 9.70 GBP | −2.02% | −2.02% | −7.62% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| FARN.L | Faron Pharmaceuticals Oy | 41.00 GBP | −4.65% | −78.97% | −79.24% |
| 4BB.L | 4basebio PLC | 470.00 GBP | −10.48% | −23.58% | −46.89% |
| EAH.L | ECO Animal Health Group plc | 99.00 GBP | +1.54% | −6.60% | +34.69% |
| CREO.L | Creo Medical Group PLC | 12.88 GBP | −5.50% | +26.85% | −1.90% |
| POLB.L | Poolbeg Pharma PLC | 8.60 GBP | +36.51% | +120.51% | +164.62% |
| OBI.L | Ondine Biomedical Inc. | 11.75 GBP | −14.55% | +34.29% | −24.19% |
| KOO.L | Kooth plc | 146.00 GBP | −3.63% | +26.96% | −7.59% |
| STX.L | Shield Therapeutics plc | 4.85 GBP | −15.65% | −50.76% | −37.42% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| HVO.L | hVIVO plc | 6.50 GBP | −10.34% | +1.56% | −35.00% |
| BVC.L | BATM Advanced Communications Ltd. | 12.30 GBP | −3.91% | −23.36% | −21.90% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 588.00 GBP | −8.12% | +3.52% | +70.43% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +10.38% | +16.53% | +17.03% |
| COIL.L | Coiled Therapeutics plc | 9.50 GBP | −9.52% | −20.83% | −26.92% |
| MPAL.L | MedPal AI PLC | 3.75 GBP | +22.95% | −25.00% | −40.00% |
| NCYT.L | Novacyt S.A. | 43.50 GBP | +17.73% | +21.00% | +7.81% |
| ABDX.L | Abingdon Health Plc | 10.75 GBP | +4.88% | +67.97% | +104.76% |
| AREC.L | Arecor Therapeutics plc | 66.00 GBP | +3.94% | −22.35% | +3.94% |
| PXS.L | Provexis plc | 1.09 GBP | −7.63% | +23.16% | +51.39% |
| IMM.L | ImmuPharma plc | 3.41 GBP | −24.22% | −45.00% | +89.66% |
| GDR.L | genedrive plc | 1.30 GBP | +33.33% | +48.57% | +67.74% |
| RENX.L | Renalytix Plc | 4.30 GBP | +62.26% | −27.12% | −26.50% |
| RUA.L | RUA Life Sciences plc | 28.00 GBP | +9.80% | +103.64% | +130.93% |
| IXI.L | IXICO plc | 7.75 GBP | −8.82% | −34.04% | −36.73% |
| COG.L | Cambridge Cognition Holdings Plc | 31.00 GBP | −6.06% | +10.71% | −4.62% |
| IHC.L | Inspiration Healthcare Group plc | 18.30 GBP | −1.08% | +24.07% | −19.74% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −79.17% |
| FAB.L | Fusion Antibodies plc | 11.25 GBP | +9.76% | −16.67% | −23.73% |
| THAT.L | Thalia Therapeutics Plc | 0.65 GBP | −3.70% | +23.81% | +52.94% |
| GENF.L | Genflow Biosciences plc | 2.00 GBP | +23.08% | +2.56% | +166.67% |
| APTA.L | Aptamer Group PLC | 0.38 GBP | −21.05% | −63.94% | −62.50% |
| CRTX.L | CRISM Therapeutics Corporation | 11.50 GBP | +21.05% | +15.00% | +9.52% |
| SVNS.L | Solvonis Therapeutics plc | 0.12 GBP | −11.59% | −61.88% | −55.64% |
| GENI.L | GENinCode Plc | 0.90 GBP | +12.50% | −62.50% | −35.71% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | 1.50 GBP | −26.83% | −3.23% | +7.14% |
| OPTI.L | OptiBiotix Health Plc | 5.65 GBP | −1.74% | −16.30% | −51.91% |
| PRM.L | Proteome Sciences plc | 1.59 GBP | −11.94% | −44.39% | −44.39% |
| VRCI.L | Verici Dx plc | 0.23 GBP | −35.71% | −68.97% | −57.14% |
| OBD.L | Oxford BioDynamics Plc | 0.12 GBP | −1.60% | −50.80% | −74.11% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| NFX.L | Nuformix plc | 0.16 GBP | +6.71% | −46.10% | +80.68% |
| TCF.L | Theracryf Plc | 0.19 GBP | −2.56% | −5.00% | −20.83% |
| SUN.L | Surgical Innovations Group plc | 0.43 GBP | −15.00% | −5.56% | −39.29% |
| FDBK.L | Feedback plc | 6.85 GBP | +13.22% | −36.28% | −48.30% |
| PYC.L | Physiomics Plc | 0.52 GBP | +7.29% | +80.70% | +21.18% |
| FUM.L | Futura Medical plc | 0.39 GBP | −2.26% | −68.29% | −95.67% |
| BSFA.L | BSF Enterprise Plc | 1.15 GBP | +43.75% | −39.47% | −48.89% |
| VAL.L | ValiRx plc | 0.16 GBP | +3.33% | −57.53% | −73.04% |
| IBAI.L | Imaging Biometrics Ltd. | 0.64 GBP | +5.83% | −25.29% | +2.42% |
| CHLL.L | Chill Brands Group PLC | 2.00 GBP | −9.09% | −74.19% | −87.88% |
| TRLS.L | Trellus Health plc | 0.04 GBP | +3233.33% | −90.00% | −94.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.